NZ Shares Dip While Asia Gains; Meridian Gets Wind Farm Consent, AFT Chair to Retire

Week-End Market Roundup: NZ Slips, Meridian Clears Consent, AFT Chair Transition

New Zealand shares ended Friday in the red while most Asian markets posted gains, a divergence driven by Wall Street's powerful Thursday rally and a tepid response to a mixed set of domestic data. The S&P 500 climbed 1.7%, the Nasdaq Composite added 2.8%, and the Dow Jones rose 1.2% overnight, lifting bourses from Seoul to Singapore. South Korean equities recovered sharply after a steep midweek drop.

At home, consumer confidence perked up to 99.3 in July, an eight-point rise, but remained below its January peak and was tempered by the effect of a fresh interest rate hike and volatile oil prices, ANZ Research noted. Separate central bank data showed lending by registered banks and non-banks grew in June, driven by housing, business and agricultural borrowers, while personal consumer credit edged lower month on month. Despite those pockets of strength, the local benchmark index closed lower.

On the corporate front, Meridian Energy secured the final major resource consent from Palmerston North City Council for the 172-megawatt repowering of its Te Rere Hau wind farm in Manawatū. The approval removes one of the last regulatory hurdles before the project can move to a final investment decision. Separately, AFT Pharmaceuticals said chair David Flacks intends to retire within the next 12 months once a successor is found. The company described the move as orderly and framed it as a planned phase in its governance evolution.

Behind the Moves: Why NZ Lagged, and What the Corporate Updates Mean

Why New Zealand Lagged Its Asian Peers

While Asian markets broadly rode the wave of US optimism and geopolitical hopes around tentative Gaza ceasefire talks, New Zealand's equity market failed to join in. A likely culprit is the lingering shadow of the Reserve Bank of New Zealand's most recent interest rate increase, which historically weighs on rate-sensitive sectors such as property and utilities that account for a meaningful share of the NZX. The lift in consumer confidence, though encouraging, was described by ANZ as still subdued relative to the start of the year, and the accompanying note flagged continued concern over oil prices. The lending data told a similar story: business and housing credit expansion signals economic activity, but the dip in personal consumer lending hints at fragile household sentiment. For a market already navigating a high-rate environment, the mixed numbers were not enough to overcome the pull of global caution.

Meridian's Wind Farm Repowering Clears a Key Hurdle

Gaining resource consent is a significant milestone for Meridian Energy. Te Rere Hau is a mature wind site, originally commissioned in two stages between 2006 and 2009. The 172 MW repowering—replacing older turbines with more efficient modern units—will boost capacity and reliability, extending the asset's life and improving returns. The consent from Palmerston North City Council was the outstanding piece among several approvals, so the project can now advance toward a final investment decision. For Meridian, a successful upgrade would reinforce its portfolio of renewable generation at a time when corporate and government demand for clean energy is rising, and it positions the company to capture higher prices during dry hydro periods when wind output is especially valuable.

AFT Pharmaceuticals Enters a Leadership Pivot

David Flacks's intention to step down within 12 months gives the board ample time to run a structured succession process. AFT has grown from a niche pain management player into a broader healthcare company with a pipeline of over-the-counter and prescription products. While retirement of a long-serving chair can raise questions about strategic direction, the extended handover period minimises disruption risk. The key variable for investors will be whether the new chair brings a fresh emphasis—for example, on overseas licensing deals or M&A—that could shift the company's growth trajectory. A well-managed transition at the top of the board is unlikely to shake short-term confidence, but the identity and background of the successor will matter for medium-term strategy.

What Investors Should Watch on the NZ Market and These Two Stocks

• Investors positioned in rate-sensitive New Zealand stocks should watch the Reserve Bank of New Zealand's next Official Cash Rate review. If the bank signals further tightening, the divergence between domestic shares and buoyant Asian markets could persist.
• Meridian Energy now has the regulatory green light to finalise investment plans for Te Rere Hau. Shareholders can expect a capital expenditure update and potentially a construction timeline in the coming months; the project, once complete, would add stable renewable generation revenue.
• AFT Pharmaceuticals' board has flagged the chair search. As the company names Flacks's successor, investors should assess any accompanying strategic statement—particularly whether management hints at accelerated international expansion or a sharper focus on its core pain relief and hospital products.